Search Results 201-210 of 17347 for hba1c

  1. Type 1 diabetes - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  2. Mayo Clinic

    Share · Tweet. Nov. 06, 2014 . VID-20116660. Home; YouTube - Mayo Clinic Led Study on Long QT Syndrome Sheds Light on Genetic Testing ...

  3. A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP) - Mayo Clinic

    Presence of a hemoglobinopathy or other condition that is expected to affect the measurement of HbA1c. Pregnant (positive urine hCG), breast feeding, plan ...

  4. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

    Mayo Clinic cardiologists, cardiovascular surgeons and others perform clinical research to develop new treatments and approaches to reduce the risk of heart ...

  5. A Study of ATR-101 for the Treatment of Cushing’s Syndrome - Mayo Clinic

    Uncontrolled diabetes mellitus, as evidenced by HbA1c > 9.0% at screening; Uncontrolled hypertension, defined as systolic blood pressure > 160 mmHg or ...

  6. Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE) - Mayo Clinic

    ... [HbA1c] ≥ 6.5%, or on anti-diabetic medication for at least 1 year); or dyslipidemia (triglycerides ≥150 mg/dL or on drug therapy for hypertriglyceridemia ...

  7. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

    Subjects with uncontrolled diabetes, as defined by HbA1c > 7%. 9. Subjects who have used the following medications: - Methotrexate within 90 days of ...

  8. Longitudinal Effects of Diabetes-Associated Variation in TCF7L2 on Glucagon and Insulin Secretion in Non-Diabetic Humans - Mayo Clinic

    The goal of this study is to determine the role of postprandial glucagon suppression and insulin secretion in the progression of glucose intolerance in people ...

  9. A Study of Simvastatin Therapy for Moderate and Severe COPD - Mayo Clinic

    Elevated HbA1c > 6.5%. It is at the discretion of the Principal Investigator if the potential participant will not be a reliable study subject to complete ...

  10. Study Evaluating the Safety, Tolerability, and Effectiveness of EDP-305 in Subjects with Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... HbA1c of at least 6% with or without concomitant treatment with metformin. AND. Screening MRI-PDFF with >8% steatosis;; Body mass index (BMI) >25 kg/m2. NOTE ...